Branding Containment Doctors Generic Drugs 
Druggist
SEPTEMBER 30, 2020
Buscopan and mebeverine are two common drugs used for symptomatic treatment of irritable bowel syndrome (IBS). Both drugs can be prescribed by a doctor or purchased over the counter from pharmacies and in case of Bucopa IBS relief from supermarkets. Buscopan vs Mebeverine lists similarities and differences between both drugs.
Druggist
MARCH 17, 2021
Lymecycline is a prescription-only medication, which means it needs to be prescribed by a doctor or another qualified prescriber for the supply to happen. Lymecycline is usually prescribed as a generic drug – lymecycline 408mg capsules or occasionally as a branded medication called Tetralysal 300 mg capsules.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Druggist
MARCH 25, 2021
Cerelle and Cerazette are two brands of daily progestogen-only pill (POP), also known as mini-pill. In recent years prescribing of Cerazette in NHS decreased, in place of other brands, including Cerelle. Can I still request a doctor to prescribe Cerazette? Do generic, and branded drugs produce exactly the same effect? .
Pharmacy Checkers
NOVEMBER 21, 2019
The FDA’s capacity to evaluate new and generic drug applications and its oversight over drug manufacturing are why we have this degree of assurance. Thousands of dedicated medical doctors, nurses, pharmacists, scientists, statisticians and other analysts are responsible for CEDR’s important work.
Druggist
OCTOBER 13, 2020
Truvada is a brand name of a combination drug, which contains two antiviral medicines: emtricitabine and tenofovir disoproxil. One important message to take away is that Truvada and equivalent generic drugs are not 100% effective. The effectiveness of Truvada for PrEP has been subject to different clinical trials.
The Pharma Data
MAY 4, 2021
down 21%, driven by a negative impact from the COVID-19 pandemic resulting in a decline in patient visits to doctors for preventative health purposes, as well as the loss of patent protection in the U.S. The information contained on our website or any third-party website is not incorporated by reference into this earnings release.
Pharmaceutical Technology
JANUARY 6, 2023
In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. Gilenya legal drama.
Expert insights. Personalized for you.
98 
Let's personalize your content